SCHEMBL25340266

SCHEMBL25340266

COCOc1c(C)c(O)c(C(=O)C=Cc2ccc(C(C)C)cc2)c(OC)c1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 2/20 0.57
▸ KCNA3 P22001 2/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ LMNA P02545 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ HTT P42858 1/20 0.43
▸ CXCL12 P48061 1/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ BACE1 P56817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25952508 1.00 ABCB1 (0.57) ABCB1KCNA3NPC1RAB9AMEN1
SCHEMBL25429661 0.89 ABCB1 (0.59) ABCB1KCNA3MEN1KMT2ALMNA
SCHEMBL25952401 0.89 ABCB1 (0.59) ABCB1KCNA3MEN1KMT2ALMNA
SCHEMBL25952507 0.89 ABCB1 (0.61) ABCB1KCNA3RAB9AMEN1KMT2A
SCHEMBL25339313 0.89 ABCB1 (0.61) ABCB1KCNA3RAB9ALMNACXCL12
SCHEMBL25952454 0.89 ABCB1 (0.61) ABCB1KCNA3RAB9ALMNACXCL12
SCHEMBL25342585 0.88 ABCB1 (0.60) ABCB1KCNA3NPC1RAB9ALMNA
SCHEMBL25339626 0.88 ABCB1 (0.60) ABCB1KCNA3RAB9AMEN1KMT2A
SCHEMBL25952460 0.88 ABCB1 (0.60) ABCB1KCNA3NPC1RAB9ALMNA
SCHEMBL25952463 0.88 ABCB1 (0.60) ABCB1KCNA3RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023177191-A1 COMPOSITION FOR PREVENTING OR TREATING FIBROTIC DISEASES, COMPRISING DIMETHYLCHALCONE DERIVATIVE AS ACTIVE INGREDIENT 서울대학교 산학협력단 2023-09-21 — — WO disclosed
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) 2023-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE LIPC, PC, CYP27A1 ABCB1 3180/4885KCNA3 4014/4885NPC1 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback